S.  No.

Title

Period

Funding agency

Amount (in lakhs of Rs.)

Project P.I

1

Self-assembled smart nano medicine for targeted therapy of advanced non-small cell lung cancer

36 Months

ICMR

21.27 Lakhs

M.S. Muthu

2

Defining the AMR burden of antimicrobial manufacturing waste in Puducherry and Chennai

36 Months

DBT

106.50 Lakhs

M.S. Muthu

3

Exploring Anti-infective Potential of Panchagavya: Metabolomics and Proteomics Approaches

2022-2024

Govt of India.

65.43 Lakhs

Shreyans Kumar Jain

4

Bioluminescence based monitoring of tumor progression and treatment by apoptotic pathway

2019-2024

DBT

42.50 Lakhs

Deepak Kumar

5

Discovery of novel selective inhibitors of choline acetyltransferase: lead optimization and in vivo pharmacokinetic studies

Jan, 2022-Dec, 2023

SERB-SRG, India 

32.86 Lakhs

Rajnish Kumar

6

Development of a toolkit for prediction of blood-brain-barrier permeability using deep learning to expedite CNS drug discovery

Jan, 2022-Dec, 2024
 

SERB-MATRICS, India

6.60 Lakhs

Rajnish Kumar

7

Development of Novel Therapeutics for the Redemption from Burn and Frostbite Burn Injury Induced Pain in Military Veterans

Jan, 2021 – Dec, 2023

SERB, India

40.81 Lakhs

Rajnish Kumar &

Vinod Tiwari

8

Pharmacological evaluation of anti-diabetic effects of some natural drugs sponsored by Industry.

2019-2022

Natreon Inc

28.87 Lakhs

Sairam Krishnamurthy

9

Pharmacology of Natural Drugs in Obesity and Eating Disorders” sponsored by Industry.

2018-20222

Natreon Inc

26.54 Lakhs

Sairam Krishnamurthy

10

Synthesis and evaluation of diverse n-functionalized hybrids as muti-target directed ligands for neuroprotective and neurorestorative therapies

2020-2024

MoE, STARS

75.30 Lakhs

Senthil Raja A

11

Design and Development of Molecular hybrids in a multifunctional framework for regulating cholinesterases, β-secretase 1, Amyloid β and oxidative stress against Alzheimer’s disease

Dec 2021-Dec. 2024

ICMR

28.87 Lakhs

Sushant Kumar Shrivastava

12

Design and Development of potential multifunctional molecular hybrids for the treatment of Alzheimer’s disease

Jan. 2022 Jan. 2025

SERB

28.28 Lakhs

Sushant Kumar Shrivastava

13

Development of Novel Therapeutics for the Redemption from Frostbite and Burn Injury-induced Chronic Pain in Military Veterans

2020 - 2023

SERB, CRG

40.81 Lakhs

Vinod Tiwari

14

Development of Transient Receptor Potential Ankyrin-1 (TRPA1) Nociceptor

based siRNA Nano-Therapeutics for the Treatment of Chemotherapy-induced Neuropathic Pain

2020 - 2023

ICMR-SRF

15.21 Lakhs

Vinod Tiwari

15

Development of Multifunctional Dendrimer Stabilized Green Nano-

Therapeutics for the Treatment of Drugs and Alcohol Addiction

2019 - 2022

ICMR-SRF

13.20 lakhs

Vinod Tiwari

16

Crystal Engineering of Dapagliflozin to improve its ph7armaceutical properties

2021 - 2023

SERB-DST, India

31.40 Lakhs

Dinesh Kumar

17

Safety and Efficacy of PL05

2022 - 2023

Purobien Lifesciences

19.00 Lakhs

S. K. Mishra